'''Treosulfan''' is a [[Chemical substance|substance]] that is being studied in the treatment of [[cancer]].<ref name="pmid16971664">{{cite journal  |vauthors=Schmittel A, Schmidt-Hieber M, Martus P, etal |title=A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma |journal=Ann. Oncol. |volume=17 |issue=12 |pages=1826â€“9 |date=December 2006 |pmid=16971664 |doi=10.1093/annonc/mdl309 |url=http://annonc.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=16971664}}</ref> It belongs to the family of drugs called [[alkylating agents]]. It has been used mainly as a substitute of [[busulfan]] in frail patients, as the side effects and [[toxicity]] are supposedly less severe.
